about
Engineered Swine Models of CancerThe impact of comorbidity on cancer and its treatmentGeriatric assessment for oncologistsLifestyle Factors in Cancer Survivorship: Where We Are and Where We Are HeadedAdjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans.Age-specific cancer survival in Estonia: recent trends and data quality.[The parameter "relative survival": Analysis of regional cancer registry data for prostate cancer].Predicting Individualized Postoperative Survival for Stage II/III Colon Cancer Using a Mobile Application Derived from the National Cancer Data BasePatients with soft tissue sarcoma comprise a higher probability of comorbidities than cancer-free individuals. A secondary data analysis.Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities.The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database.Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.Obesity and Prognostic Variables in Colombian Breast Cancer Patients: A Cross-Sectional Study.Individual- and neighborhood-level predictors of mortality in Florida colorectal cancer patientsProvision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland.Mining cancer-specific disease comorbidities from a large observational health databaseValidation of disability status, a claims-based measure of functional status for cancer treatment and outcomes studiesGeneralizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in ChicagoFinding directionality and gene-disease predictions in disease associations.Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.How to model temporal changes in comorbidity for cancer patients using prospective cohort dataOne-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic Score2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?Ten-Year Mortality after a Breast Cancer Diagnosis in Women with Severe Mental Illness: A Danish Population-Based Cohort Study.Comorbidities and Quality of Life among Breast Cancer Survivors: A Prospective StudyAge-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation.The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities.Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004-2013.Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.Palliative Care Teams' Cost-Saving Effect Is Larger For Cancer Patients With Higher Numbers Of Comorbidities.Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan.Adverse health behaviours among colorectal cancer survivors: a case study from IranComorbidity in older adults with cancer.Socioeconomic Factors Impact Inpatient Mortality in Pediatric Lymphoma Patients.Inclusion of populations at risk of advanced melanoma in an opportunistic targeted screening project involving general practitioners.Atmospheric fine particulate matter and breast cancer mortality: a population-based cohort study.Identification of disease comorbidity through hidden molecular mechanismsAssessment of comorbidities in surgical oncology outcomes.Adjuvant systemic treatment for elderly breast cancer patients; addressing safety concerns.
P2860
Q26744575-6AB9A7DB-E787-4132-A13F-BD585BD3C8CEQ26764935-0C8B1D9D-750C-4B1D-A42B-76230A9EA36EQ26771403-87497B5B-D8B3-48DB-94A2-44092E4D5242Q27011454-B4C65B34-8E08-40FA-A33A-99BED6006592Q30625567-2C67BCE7-9E33-430E-9EDB-6E70007819B4Q30985736-A231E969-14C9-4FBA-B39A-A6AD4C79255FQ30992920-3B0FB6D5-59B5-4A02-B77C-76601D720E0EQ31049742-66F9996C-110A-4627-96F8-8CC9D56D36EEQ31148452-0D27682C-1A01-43CD-8966-F01989353BD6Q31171263-FED05100-1FC0-4871-AFBA-9E2729D159C3Q33639932-6CCE7735-5B8A-4544-BA84-D1D1E48B64EBQ33665450-342CE4FB-CECD-4290-B89E-2825E5AFC033Q33747941-C38C3DD8-86F4-4C3D-9DF2-FA3F989A2975Q34110499-B34D7FAF-033F-41E2-8C6B-6403B99F4FCFQ34423099-5AC6C531-1288-4AF0-919E-0EE80F03F852Q34434844-8653CC64-BF71-4743-B0F2-0C1283CA2D43Q34637063-2C6A42AF-6780-460A-9BDF-FD6BC3B02582Q34736580-0A5D58FE-8E78-424C-8996-5FB326BA1F91Q35647075-662F8633-B697-4891-BF93-3E4F58160A70Q35689793-1E1797E1-05FD-4834-863E-E159E768D76FQ35709269-F8B8C85A-D72C-4340-B9AA-3DECEB497F09Q35845867-0D154194-75BA-47C9-ABB5-308DC08B2392Q35918084-1F86837E-61F0-4DC0-BF49-884BE13C1612Q36037785-7256EFFA-4B25-437A-A80B-D528ABC32327Q36086996-19EA0D88-E35E-4EE8-A2F4-0774756D8CC4Q36143720-BAD86AD1-1F34-45A7-9EAE-BAF92C26ABCAQ36151471-95A66CC9-A392-447A-892B-97036FFF5E1FQ36316360-06A5B39A-E10B-489E-9FAF-CFD87AA088BDQ36383286-7DD0199D-4503-40D4-92B3-0C0EADE63103Q36782920-E1E2C61C-549D-4EF4-81C0-739259A2A7DFQ36847843-89E826EF-9B92-48FD-9714-288795D579D5Q36882604-FC4F8A0B-CD08-4E65-8A21-0FCD6EADCBD8Q36936995-86802359-4E9F-4C2A-9306-3D37B9D294E5Q37029899-01C7D836-5560-47B6-9258-A6C21FE70CF0Q37069880-29187D71-8342-42C9-87E8-A0655B374818Q37281896-A8B70C85-6CC8-4254-A308-BBD3842B4034Q37455153-D9852F1B-8060-4A4A-A62F-077E1CEB07DEQ37519334-346B3098-F65E-4E8D-98EA-8976C76CB7C5Q38237623-0584BECE-D5A8-4D37-B64D-889FE82B3BDBQ38253136-51942737-0351-4657-9456-80C1E05A3A55
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The impact of comorbidity on cancer survival: a review
@en
The impact of comorbidity on cancer survival: a review.
@nl
type
label
The impact of comorbidity on cancer survival: a review
@en
The impact of comorbidity on cancer survival: a review.
@nl
prefLabel
The impact of comorbidity on cancer survival: a review
@en
The impact of comorbidity on cancer survival: a review.
@nl
P2860
P50
P356
P1476
The impact of comorbidity on cancer survival: a review
@en
P2093
Kristine Skovgaard Bossen
P2860
P356
10.2147/CLEP.S47150
P407
P433
P577
2013-11-01T00:00:00Z